you'll have more options to help patients get a suitable atypical antipsychotic

February 2011

The approval of Latuda (lurasidone) means you'll have more options to help patients get a suitable atypical antipsychotic.

More money is spent on antipsychotics than any other class.

That's because these drugs are being used more for bipolar disorder, depression, autism, etc. Plus most cost $15 to $20 per day.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote